-
Investing
A New K-12 Productivity Chart
Neal McCluskey Over the years, many people have inquired about updating the chart below, which plots change in academic achievement for…
Read More » -
Investing
Another Stopgap Funding Bill, Another Budget Failure
Romina Boccia and Dominik Lett Congress is barreling toward a March 14 discretionary funding deadline with no agreement in sight.…
Read More » -
Investing
The Coming Trump Travel Bans Will Seek to Exclude a Small Terrorist Threat
Alex Nowrasteh The Trump administration is preparing several travel and immigration bans for people from different countries that could be…
Read More » -
Investing
Freedom, Not Tariff, Is the Most Beautiful Word in the Dictionary
James A. Dorn President Trump likes to say, “The word tariff is the most beautiful word in the dictionary”; tariffs “make…
Read More » -
Investing
The Drug War Is Failing, So Let’s Try… Tariffs?
Jeffrey A. Singer In an interview by ABC News’ Jonathan Karl on March 9, White House National Economic Council Director…
Read More » -
Economy
What does “PhD-level” AI mean? OpenAI’s rumored $20,000 agent plan explained.
The AI industry has a new buzzword: “PhD-level AI.” According to a report from The Information, OpenAI may be planning…
Read More » -
Economy
Nearly 1 million Windows devices targeted in advanced “malvertising” spree
Nearly 1 million Windows devices were targeted in recent months by a sophisticated “malvertising” campaign that surreptitiously stole login credentials,…
Read More » -
Investing
Breaking the NIMBY Feedback Loop in Vermont
Stephen Slivinski and Yasmeen Kallash-Kyler Housing policy reform is tricky. Getting policy changes off the ground in the first place…
Read More » -
Investing
Trump’s Tariff Walkback Bows to Economic Reality but Leaves Plenty of Problems
Alfredo Carrillo Obregon and Scott Lincicome On March 6, President Donald Trump exempted Canadian and Mexican imports that enter the US…
Read More » -
Investing
The FDA Finally Removes a Huge Barrier to an Effective Schizophrenia Medicine
Jeffrey A. Singer As Josh Bloom and I wrote last November, the Food and Drug Administration (FDA) imposed onerous requirements…
Read More »